Latest News about BCRX
Recent news which mentions BCRX
Why BioCryst Pharmaceuticals Stock Is Jumping on Monday
January 10, 2022
Tickers
BCRX
From Motley Fool
45 Stocks Moving In Monday's Mid-Day Session
January 10, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
December 10, 2021
From Benzinga
8 Beaten-Down Pharmaceutical Stocks That Could Skyrocket In 2022
December 07, 2021
From Motley Fool
2 Ultra-High-Yield Dividend Stocks to Buy as a Hedge Against Inflation
November 30, 2021
From Motley Fool
3 Incredibly Cheap Growth Stocks That Could Make You a Millionaire
November 29, 2021
From Motley Fool
3 Stocks Insiders Are Buying
November 26, 2021
From Benzinga
BioCryst Shares Gain As Royalty Pharma Buys Additional Interests In BCX9930, Orladeyo
November 22, 2021
From Benzinga
7 Top Growth Stocks to Buy as We Step Into November
November 12, 2021
From InvestorPlace
86 Biggest Movers From Yesterday
November 04, 2021
From Benzinga
BioCryst Pharmaceuticals (BCRX) Q3 2021 Earnings Call Transcript
November 03, 2021
Tickers
BCRX
From Motley Fool
Here's Why BioCryst Pharmaceuticals Stock Is Losing Ground Today
November 03, 2021
From Motley Fool
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 03, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 03, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 20, 2021
From Benzinga
7 Best Growth Stocks to Buy and Hold for the Next 10 Years
October 18, 2021
From InvestorPlace
2 Super-Charged Growth Stocks to Buy Now
October 13, 2021
From Motley Fool
3 Biotech Stocks Wall Street Thinks Could Rise 44% or Better
September 30, 2021
From Motley Fool
US Government Exercises Option To Buy Additional Doses Of BioCryst's Flu Med
September 01, 2021
Tickers
BCRX
From Benzinga
From Benzinga
2 Soaring Biotech Stocks With More Fuel in the Tank
August 23, 2021
From Motley Fool
Analyzing BioCryst Pharmaceuticals's Unusual Options Activity
August 16, 2021
Tickers
BCRX
From Benzinga
Analyzing BioCryst Pharmaceuticals's Unusual Options Activity
August 11, 2021
Tickers
BCRX
From Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
From Benzinga
BioCryst Stock Jumps After Pulling Out $200M Equity Raise
August 11, 2021
Tickers
BCRX
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 11, 2021
From Benzinga
22 Stocks Moving in Wednesday's Pre-Market Session
August 11, 2021
From Benzinga
85 Biggest Movers From Yesterday
August 11, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.